• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers.

作者信息

Ogata H, Zugarni S, Ejima A, Kawatsu Y

出版信息

Eur J Clin Pharmacol. 1983;24(6):791-6. doi: 10.1007/BF00607089.

DOI:10.1007/BF00607089
PMID:6688397
Abstract

The relative bioavailability and diuretic effect of 2 commercially available tablet preparations of furosemide 40 mg was examined in 10 healthy male volunteers. A close linear relationship between the urinary excretion rate of furosemide and the rate of sodium ion excretion in urine and/or flow rate of urine was demonstrated. There were no significant differences in the urinary excretion of furosemide, sodium and potassium ions or urinary volume following the oral doses. The difference in drug content affected the urinary recovery of furosemide over 24 h but had no effect on the pharmacological response. The analytical power of ANOVA using the various parameters of the responses to furosemide was no lower than when the parameters of urinary excretion of furosemide were used.

摘要

相似文献

1
Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers.
Eur J Clin Pharmacol. 1983;24(6):791-6. doi: 10.1007/BF00607089.
2
Comparative bioavailability of two furosemide formulations in humans.两种呋塞米制剂在人体中的相对生物利用度。
J Pharm Sci. 1984 Apr;73(4):437-41. doi: 10.1002/jps.2600730404.
3
Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.速尿普通片剂和缓释胶囊在正常受试者及肝硬化患者中的临床药代动力学和利尿作用
J Pharmacobiodyn. 1983 Sep;6(9):684-91. doi: 10.1248/bpb1978.6.684.
4
The pharmaceutical and biological availability of commercial preparations of furosemide.
Arzneimittelforschung. 1982;32(6):693-7.
5
Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.速尿片剂和缓释胶囊剂给予人体受试者后的生物利用度及利尿作用
Biol Pharm Bull. 1996 Apr;19(4):616-22. doi: 10.1248/bpb.19.616.
6
Variable furosemide absorption and poor predictability of response in elderly patients.老年患者中呋塞米吸收可变且反应预测性差。
Pharmacotherapy. 1997 Jan-Feb;17(1):98-106.
7
Gender effect on diuretic response to hydrochlorothiazide and furosemide.性别对氢氯噻嗪和呋塞米利尿反应的影响。
Int J Clin Pharmacol Ther. 1996 Mar;34(3):101-5.
8
Diuretic effect of a combined preparation of frusemide and slow-release potassium chloride.速尿与缓释氯化钾复方制剂的利尿作用
Curr Med Res Opin. 1978;5(9):739-42. doi: 10.1185/03007997809110215.
9
Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.根据速尿的尿回收率估算的生物利用度与总利尿效果之间的差异。
Br J Clin Pharmacol. 1992 Jul;34(1):47-52. doi: 10.1111/j.1365-2125.1992.tb04106.x.
10
Bioavailability of two preparations of frusemide.两种速尿制剂的生物利用度。
N Z Med J. 1980 Mar 26;91(656):208-10.

引用本文的文献

1
Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers.对不同受试者数量的各种双氯芬酸生物等效性试验的统计功效函数进行评估。
Eur J Drug Metab Pharmacokinet. 2009 Apr-Jun;34(2):85-91. doi: 10.1007/BF03191156.
2
Bioavailability and diuretic effect of furosemide during long-term treatment of chronic respiratory failure.
Eur J Clin Pharmacol. 1985;28(1):53-9. doi: 10.1007/BF00635708.
3
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).呋塞米。药代动力学/药效学综述(第二部分)。

本文引用的文献

1
Preliminary evaluation of furosemide-probenecid interaction in humans.速尿-丙磺舒在人体中的相互作用的初步评估。
J Pharm Sci. 1980 May;69(5):571-5. doi: 10.1002/jps.2600690526.
2
Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.肝硬化和终末期肾病对呋塞米药代动力学和药效学的影响。
Eur J Clin Pharmacol. 1981;20(1):27-33. doi: 10.1007/BF00554663.
3
Furosemide kinetics in patients with hepatic cirrhosis with ascites.肝硬化腹水患者中呋塞米的动力学
Clin Pharmacokinet. 1990 Jun;18(6):460-71. doi: 10.2165/00003088-199018060-00003.
Clin Pharmacol Ther. 1981 Oct;30(4):461-7. doi: 10.1038/clpt.1981.189.
4
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.理解剂量-效应关系:药代动力学-药效学模型的临床应用
Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.
5
Clinical pharmacokinetics of diuretics.利尿剂的临床药代动力学
Clin Pharmacokinet. 1980 May-Jun;5(3):221-45. doi: 10.2165/00003088-198005030-00003.
6
Bioavailability of two preparations of frusemide.两种速尿制剂的生物利用度。
N Z Med J. 1980 Mar 26;91(656):208-10.
7
Furosemide. A clinical evaluation of its diuretic action.
Circulation. 1966 Nov;34(5):910-20. doi: 10.1161/01.cir.34.5.910.
8
Determinants of response to frusemide in normal subjects.正常受试者对速尿反应的决定因素。
Br J Clin Pharmacol. 1977 Apr;4(2):121-7. doi: 10.1111/j.1365-2125.1977.tb00682.x.
9
Bioavailability of two frusemide preparations.两种速尿制剂的生物利用度。
Br J Clin Pharmacol. 1978 Dec;6(6):537-8. doi: 10.1111/j.1365-2125.1978.tb00880.x.
10
Bioavailability of imipramine tablets relative to a stable isotope-labeled internal standard: increasing the power of bioavailability tests.相对于稳定同位素标记内标物的丙咪嗪片生物利用度:提高生物利用度测试的效能
J Pharmacokinet Biopharm. 1979 Jun;7(3):233-48. doi: 10.1007/BF01060015.